C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
12/2004
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/16/2004	WO2004108722A1 Orthocondensed polycyclic aminopyrrole derivatives comprising an electro-attractive substituent, combination products of said derivatives, and method for the production thereof
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254372 Poly(adenosine 5'-diphospho-ribose)polymerase (PARP) inhibitor; for treating or preventing neurological, genetic, autoimmune, nervous system, cardiovascular disorders, cancer; such as myocardial infarction, angina pectoris and cardiogenic shock
12/16/2004	US20040254371 New benzothiazine and benzothiadiazine compounds
12/16/2004	US20040254199 For plants, animals; nematocides
12/16/2004	US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants
12/16/2004	US20040254161 New benzothiazine and benzothiadiazine compounds
12/16/2004	US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression
12/15/2004	EP1486503A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
12/15/2004	EP1486502A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
12/15/2004	EP1486501A1 Aminomethyl-substituted thiazolobenzimidazole derivative
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/13/2004	CA2470263A1 New benzothiazine and benzothidiazine derivatives, their process of production and pharmaceutical compositions contained therein
12/13/2004	CA2470065A1 New derivatives of benzothiazine and benzothidiazine, preparation process thereof, and the pharmaceutical compounds containing them
12/09/2004	WO2004106492A2 Bicyclicpyrimidones and their use to treat diseases
12/09/2004	WO2004106348A1 Aminomethyl-substituted fluorothiazolobenzimidazole derivative
12/09/2004	WO2004106293A2 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
12/09/2004	US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004	DE10320732A1 Rapid-acting anesthetics with short duration of action, especially useful during surgical intervention, comprises thiazolo-(3,2-a)-(1,3)-diazepine-3-carboxylic acid derivatives
12/08/2004	EP1483269A1 Racemization and enantiomer separation of clopidogrel
12/08/2004	EP1482933A2 Potent, simplified derivatives of immunosuppressive agents
12/08/2004	EP1157013B1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments
12/08/2004	EP0831094B1 Fused polycyclic heterocycle derivatives
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553773A Thiazolo [4,5-b]pyridines as fungicides
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178661C Use of brinzolamide to prevent visual field loss
12/07/2004	US6828326 Pyrimidinone fused bicyclic metalloproteinase inhibitors
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2156734C Ozonide reducing agent
12/07/2004	CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
12/07/2004	CA2147755C 6-(substituted methylene) penems and intermediates
12/02/2004	WO2004104006A2 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR IN INTERMEDIATES
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004024074A3 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
12/02/2004	US20040242874 Process for synthesizing beta-lactamase inhibitor intermediates
12/02/2004	US20040242866 Tricyclic benzodiazepines as vasopressin receptor antagonists
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242596 such as N-(3-Amino-propyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-propyl]-4-chloro-benzamide; for interrupting mitosis; antiproliferatives and anticancer agents
12/02/2004	CA2525507A1 Process for synthesizing .beta.-lactamase inhibitor intermediates
12/02/2004	CA2525504A1 Process for synthesizing .beta.-lactamase inhibitor in intermediates
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1480986A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/01/2004	EP1480970A1 Quinoline derivatives
12/01/2004	EP1480640A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
11/2004
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825184 For use as anti-inflammatory agents
11/25/2004	WO2004101573A1 Synthesis of substituted heterocyclic compounds
11/25/2004	WO2004101570A1 Sulfur-containing naphthoylimide derivatives
11/25/2004	WO2004089356A3 Targeted bone marrow protection agents
11/25/2004	WO2004021984A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235841 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
11/25/2004	CA2524706A1 Synthesis of substituted heterocyclic compounds
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6822062 Supported group 8-10 transition metal olefin polymerization catalysts
11/23/2004	US6821993 Bioavailable small molecule mimetics of neurotrophic factors that are orally bioavailable and can readily penetrate the blood-brain barrier
11/18/2004	WO2004099217A1 Thiadiazine derivatives and use thereof as positive ampa receptor modulators
11/18/2004	WO2004099204A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/16/2004	US6818764 Process for preparing substance GM-95
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/11/2004	WO2004096815A1 Crystals of quinolinecarboxylic acid derivative solvate
11/11/2004	WO2004096366A1 9-azabicyclo’3.3.1!non-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004078110A3 Fused imizadoles as transforming growth factor (tgf) inhibitors
11/11/2004	WO2004056879A8 Spirotetrathiocarbamates and spirooxothiocarbamates
11/11/2004	US20040225000 4-(R'-Imino)-3-Mercapto-5-(R)4H-1,2,4-Triazols, 4-(R'-imino)-3-alkylthio-5-R-1,2,4-triazoles and 4-amino-3-mercapto-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2521938A1 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors
11/10/2004	EP1475372A1 Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1174986C Tricyclic benzodiazepines as vasopressin receptor antagonists
11/09/2004	US6815439 Pyrrolo(2,3-b)pyridine derivatives as cyclin-dependent kinase inhibitors
11/04/2004	WO2004094430A1 Tricyclic indole derivatives and their use in the treatment of alzheimer’s disease
11/04/2004	WO2004087145A3 Antibacterial agents
11/04/2004	WO2004060865A3 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines

1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 152